Viewing Study NCT04147195

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:14 PM
Ignite Modification Date: 2026-01-25 @ 12:55 AM
Study NCT ID: NCT04147195
Status: TERMINATED
Last Update Posted: 2023-08-21
First Post: 2019-10-22
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH)
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-alcoholic Fatty Liver Disease View
None Nonalcoholic Steatohepatitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-alcoholic fatty liver disease View
None NAFLD View
None Non-alcoholic steatohepatitis View
None NASH View
None Platform design View
None LYS006 View
None LJN452 View
None Tropifexor View